Perrone, M.A.; Favresse, J.; D’Alessandro, A.; Albanese, F.; De Bruyne, C.; Ceccarelli, S.; Drago, F.; Guccione, P.; Porzio, O.; Leonardi, B.
Soluble Isoform of Suppression of Tumorigenicity 2 (ST2) Biomarker in a Large Cohort of Healthy Pediatric Population: Determination of Reference Intervals. J. Clin. Med. 2022, 11, 4693.
https://doi.org/10.3390/jcm11164693
AMA Style
Perrone MA, Favresse J, D’Alessandro A, Albanese F, De Bruyne C, Ceccarelli S, Drago F, Guccione P, Porzio O, Leonardi B.
Soluble Isoform of Suppression of Tumorigenicity 2 (ST2) Biomarker in a Large Cohort of Healthy Pediatric Population: Determination of Reference Intervals. Journal of Clinical Medicine. 2022; 11(16):4693.
https://doi.org/10.3390/jcm11164693
Chicago/Turabian Style
Perrone, Marco Alfonso, Julien Favresse, Annamaria D’Alessandro, Federica Albanese, Coralie De Bruyne, Stefano Ceccarelli, Fabrizio Drago, Paolo Guccione, Ottavia Porzio, and Benedetta Leonardi.
2022. "Soluble Isoform of Suppression of Tumorigenicity 2 (ST2) Biomarker in a Large Cohort of Healthy Pediatric Population: Determination of Reference Intervals" Journal of Clinical Medicine 11, no. 16: 4693.
https://doi.org/10.3390/jcm11164693
APA Style
Perrone, M. A., Favresse, J., D’Alessandro, A., Albanese, F., De Bruyne, C., Ceccarelli, S., Drago, F., Guccione, P., Porzio, O., & Leonardi, B.
(2022). Soluble Isoform of Suppression of Tumorigenicity 2 (ST2) Biomarker in a Large Cohort of Healthy Pediatric Population: Determination of Reference Intervals. Journal of Clinical Medicine, 11(16), 4693.
https://doi.org/10.3390/jcm11164693